| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.38B | 14.18B | 14.49B | 20.03B | 15.84B | 10.04B |
| Gross Profit | 3.89B | 3.07B | 2.44B | 6.51B | 5.22B | 2.24B |
| EBITDA | 3.18B | 2.37B | 1.87B | 4.62B | 3.81B | 1.58B |
| Net Income | 1.28B | 810.80M | 707.79M | 3.86B | 2.07B | 772.17M |
Balance Sheet | ||||||
| Total Assets | 22.13B | 20.94B | 21.95B | 24.64B | 21.60B | 17.12B |
| Cash, Cash Equivalents and Short-Term Investments | 3.77B | 2.75B | 3.13B | 5.45B | 5.25B | 4.43B |
| Total Debt | 70.56M | 26.44M | 32.05M | 43.63M | 664.26M | 1.95B |
| Total Liabilities | 3.51B | 3.47B | 5.01B | 6.15B | 5.96B | 6.59B |
| Stockholders Equity | 12.98B | 12.11B | 14.79B | 16.08B | 13.12B | 8.54B |
Cash Flow | ||||||
| Free Cash Flow | 309.32M | 278.14M | -536.56M | 1.24B | -43.38M | 525.19M |
| Operating Cash Flow | 1.66B | 2.07B | 1.38B | 5.08B | 3.91B | 2.26B |
| Investing Cash Flow | -1.32B | -1.50B | -2.63B | -2.91B | -4.09B | -1.96B |
| Financing Cash Flow | -192.98M | -648.37M | -1.51B | -1.96B | 999.52M | 1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$7.46B | 34.96 | 5.86% | ― | 29.64% | -3.91% | |
69 Neutral | HK$4.08B | 7.18 | 9.36% | 6.97% | -3.73% | 6.09% | |
62 Neutral | HK$16.23B | 11.74 | 10.43% | 0.93% | -1.43% | 113.67% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$1.21B | 16.88 | 3.61% | 1.85% | -8.51% | -68.34% | |
57 Neutral | HK$2.78B | 3.69 | 13.87% | ― | 9.20% | 213.87% | |
54 Neutral | HK$10.29B | -145.28 | -0.52% | 1.11% | -15.17% | -125.24% |
Dongyue Group Limited announced the quarterly results of its subsidiary, Shandong Dongyue Organosilicon Materials Co. Ltd., for the third quarter of 2025. The subsidiary reported unaudited financials, including a total asset value of RMB 6,072,803, revenue of RMB 3,026,685, and a net profit of RMB 2,857. The results highlight the company’s financial status but caution is advised as the figures are unaudited.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$11.50 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.
Dongyue Group Limited announced that its subsidiary, Shandong Dongyue Organosilicon Materials Co. Ltd., expects a significant decrease in net profit for the first three quarters of 2025, with estimates showing a drop of approximately 96.27% to 97.40% year-on-year. This substantial decline in profitability highlights potential challenges in the market or operational difficulties, urging shareholders and investors to exercise caution when dealing with the company’s securities.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$13.00 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.
Dongyue Group Limited has reported its interim financial results for the first half of 2025, showcasing a significant improvement in its financial performance. The company achieved a revenue of RMB 7,463 million, up from RMB 7,261 million in the same period last year, with a gross profit margin rising to 29.10% from 19.83%. Profit for the period attributable to owners of the company increased to RMB 779 million from RMB 308 million, highlighting strong operational efficiency and market positioning. This financial growth underscores Dongyue’s robust market strategy and potential positive implications for its stakeholders.
The most recent analyst rating on (HK:0189) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Dongyue Group Limited stock, see the HK:0189 Stock Forecast page.